Table 6.

Patient demographics and clinical characteristics

Number of patients (N)	124
Gender	44 M, 80 F
Age, yearsa,b	38 (20–70)
Weight, kgb	70.3 (45–111)
Disease duration, yearsa,c	6.3 (2.2)
EDSSa,c	4.8 (1.7)
Length of follow-up, yearsc	4.2 (2.6)
Previous therapyd	63 (50.8%)—beta interferons
	31 (25.0%)—beta interferons and copaxone
	14 (11.3%)—copaxone
	16 (12.9%)—other medications/medicine combinations

^aAt the start of treatment

^bMean (range)

^cMean (standard deviation)

^dNumber (%) of patients